摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-Amino-2-chlorphenoxy)-octan | 13738-22-2

中文名称
——
中文别名
——
英文名称
1-(4-Amino-2-chlorphenoxy)-octan
英文别名
3-chloro-4-(octyloxy)benzenamine;Aniline, 3-chloro-4-(octyloxy)-;3-chloro-4-octoxyaniline
1-(4-Amino-2-chlorphenoxy)-octan化学式
CAS
13738-22-2
化学式
C14H22ClNO
mdl
MFCD01670245
分子量
255.788
InChiKey
OXSWUIWWQVACTN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.8
  • 重原子数:
    17
  • 可旋转键数:
    8
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.571
  • 拓扑面积:
    35.2
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    1-(4-Amino-2-chlorphenoxy)-octan4-二甲氨基吡啶N,N'-二环己基碳二亚胺 作用下, 以 乙醇二氯甲烷 为溶剂, 反应 56.0h, 生成
    参考文献:
    名称:
    摘要:
    In this paper we present selected members of 7 new series of bent-shaped five-ring resorcinol derivatives which are distinguished by substituents at the central core as well as at the outer rings. Depending on the kind and position of the substituents and depending on the length of the terminal chains not only have new mesophases (the C-PA phase or three unidentified B-2-like phases) been identified, but also interesting phase sequences have been observed (B-2-N; B-2-SmA; B-2-SmA-SmC; B-2-SmA-SmC-N).
    DOI:
    10.1039/b104098g
  • 作为产物:
    描述:
    1-(2-Chlor-4-nitrophenoxy)-n-octan 在 铁粉溶剂黄146 作用下, 生成 1-(4-Amino-2-chlorphenoxy)-octan
    参考文献:
    名称:
    血吸虫病的化学疗法。第八部分 2-羧基和2-氨基甲酰基-4-氨基苯基醚
    摘要:
    通过引入羧基-,氨基甲酰基-,烷基磺酰基-和一些其他核取代基进行结构活性研究,继续进行了一系列血吸虫的对氨基苯醚的合成工作。
    DOI:
    10.1039/j39660002196
点击查看最新优质反应信息

文献信息

  • [EN] METHODS AND COMPOSITIONS FOR MODULATING SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR ACTIVITY<br/>[FR] PROCEDES ET COMPOSITIONS SERVANT A MODULER L'ACTIVITE DU RECEPTEUR DE LA SPHINGOSINE-1-PHOSPHATE (S1P)
    申请人:PRAECIS PHARM INC
    公开号:WO2006020951A1
    公开(公告)日:2006-02-23
    The present invention relates to compounds which modulate the activity of the SI P1 receptor, the use of these compounds for treating conditions associated with signaling through the S1 P1 receptor, and pharmaceutical compositions comprising these compounds.
    本发明涉及调节SI P1受体活性的化合物,以及利用这些化合物治疗与S1 P1受体信号传导相关的疾病的用途,以及包含这些化合物的药物组合物。
  • [EN] PHTHALANILATE COMPOUNDS AND METHODS OF USE<br/>[FR] COMPOSÉS DE PHTALANILATE ET LEURS PROCÉDÉS D'UTILISATION
    申请人:UNIV NOTRE DAME DU LAC
    公开号:WO2011026107A1
    公开(公告)日:2011-03-03
    The invention provides antimicrobial compounds and compositions, and methods of using them. The compounds and compositions include, for example, a compound of any one of Formulas I-X. The invention further provides methods of preparing the compounds, and useful intermediates for their preparation. The compounds can possess highly specific and selective activity, such as antibacterial activity and/or enzymatic inhibitory activity. Accordingly, the compounds and compositions can be used to treat bacterial infections, or to inhibit or kill bacteria, either in vitro or in vivo.
    本发明提供了抗微生物化合物和组合物,以及使用它们的方法。这些化合物和组合物包括,例如,I-X公式中的任何一种化合物。本发明进一步提供了制备这些化合物的方法,并提供了有用的中间体。这些化合物可以具有高度特异性和选择性活性,例如抗菌活性和/或酶抑制活性。因此,这些化合物和组合物可以用于治疗细菌感染,或者在体外或体内抑制或杀死细菌。
  • Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
    申请人:Saha K. Ashis
    公开号:US20060135786A1
    公开(公告)日:2006-06-22
    The present invention relates to compounds which modulate the activity of the S1P1 receptor, the use of these compounds for treating conditions associated with signaling through the S1P1 receptor, and pharmaceutical compositions comprising these compounds.
    本发明涉及调节S1P1受体活性的化合物,使用这些化合物治疗与S1P1受体信号传导相关的疾病,并包括这些化合物的药物组合物。
  • Methods and compositions for modulating sphingosine -1- phosphate (S1P) receptor activity
    申请人:Saha K. Ashis
    公开号:US20080064662A1
    公开(公告)日:2008-03-13
    The present invention relates to compounds which modulate the activity of the S1P1 receptor, the use of these compounds for treating conditions associated with signaling through the S1P1 receptor, and pharmaceutical compositions comprising these compounds.
    本发明涉及调节S1P1受体活性的化合物,使用这些化合物治疗与S1P1受体信号有关的疾病,并包括这些化合物的制药组合物。
  • METHODS AND COMPOSITIONS FOR MODULATING SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR ACTIVITY
    申请人:Praecis Pharmaceuticals Inc.
    公开号:EP1781595A1
    公开(公告)日:2007-05-09
查看更多